CARTHERA -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 2.687.400 0 1
2020 2.064.325 0 2.064.325 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ARJUNA THERAPEUTICS SL1
BAYER1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
GENEXPLAIN1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INTERNATIONAL BRAIN TUMOUR ALLIANCE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LABORATOIRE NATIONAL DE SANTE1
MILTENYI BIOTEC BV & CO KG1
MIMETAS BV1
OSLO UNIVERSITETSSYKEHUS HF1
ROYAL COLLEGE OF SURGEONS IN IRELAND1
RUPRECHT KARLS UNIVERSITAET HEIDELBERG1
SB SCIENCE MANAGEMENT UG1
SORBONNE UNIVERSITE1
THE BRIGHAM AND WOMEN'S HOSPITAL INC1
UNIVERSITE DU LUXEMBOURG1
VIB VZW1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment GLIORESOLVEparticipant2.687.40021
2020-10-01Delivering anti-cancer drugs beyond the blood-brain barrier DOMEUScoordinator2.064.3251